Rachel Tam's Biography

Rachel Tam, Senior Scientific Researcher, Oncology Biomarker Development, Genentech

Rachel Tam has been working in Genentech as senior scientific researcher for 8 years. She is a technical expert on multiple molecular biology technologies including qPCR, ddPCR and NGS. She has developed a high throughput multiplex microfluidics qPCR platform to detect mutations in fresh frozen, FFPE, TMA and cell free DNA samples from multiple clinical trials routinely. Recently, she has been developing ultra-sensitive assays utilizing ddPCR and NGS technologies to detect mutations from circulating tumour DNA, paving the way to develop personalized medicine for cancer patients.

Ultra-Sensitive Mutational Analysis in Cell-Free DNA by Digital PCR and NGS Technologies

Wednesday, 27 March 2019 at 15:00

Add to Calendar ▼2019-03-27 15:00:002019-03-27 16:00:00Europe/LondonUltra-Sensitive Mutational Analysis in Cell-Free DNA by Digital PCR and NGS TechnologiesLiquid Biopsies 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Circulating cell-free DNA (cfDNA) in plasma offers a non-invasive approach to monitor tumor molecular profiling in real-time at multiple time-points, detection of emerging genomic alterations associated with drug resistance and clarifying cancer prognosis and diagnosis of cancer recurrence or progression. We developed an ultra-sensitive droplet digital PCR (ddPCR) approach and molecular tagged NGS technologies to detect actionable cancer biomarkers in cfDNA.

Add to Calendar ▼2019-03-27 00:00:002019-03-29 00:00:00Europe/LondonLiquid Biopsies 2019Liquid Biopsies 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors